Published in Clin Exp Rheumatol on February 12, 2010
Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol (2012) 1.14
Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature. Rheumatol Int (2012) 0.92
Worsening of psoriasis with rituximab therapy. Clin Exp Rheumatol (2011) 0.75
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis (2004) 1.73
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int (2000) 1.50
Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scand J Rheumatol (2011) 1.41
Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes. Eur J Haematol (2001) 1.40
Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol (1997) 1.39
Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clin Exp Rheumatol (1999) 1.39
Uterine cervical involvement in a patient with Wegener's granulomatosis. Am J Med (2000) 1.38
Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.37
Laryngeal involvement in rheumatoid arthritis. Rheumatol Int (2005) 1.36
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol (2009) 1.34
Kidney involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 1.33
Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob Agents Chemother (2011) 1.28
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) (2005) 1.23
Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol (1999) 1.17
Epidemiology of adult rheumatoid arthritis in northwest Greece 1987-1995. J Rheumatol (1997) 1.16
The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol (2010) 1.15
Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol (2007) 1.13
Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol (2006) 1.12
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study. Ann Rheum Dis (2005) 1.12
Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) (2000) 1.12
Erythema nodosum: the underlying conditions. Clin Rheumatol (2000) 1.11
Renal tubular acidosis in primary Sjögren's syndrome. Clin Rheumatol (1992) 1.11
Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis (1985) 1.09
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol (1987) 1.07
Visceral leishmaniasis resembling systemic lupus erythematosus. Ann Rheum Dis (2004) 1.06
Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus (1993) 1.06
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis (2001) 1.04
The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol (1990) 1.03
Cutaneous vasculitis as the initial manifestation in acute myelomonocytic leukemia. Ann Intern Med (1994) 1.03
Secondary Sjögren's syndrome in rheumatoid arthritis. J Rheumatol (1987) 1.00
Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology (Oxford) (2004) 1.00
Urticaria and angiedema-like skin reactions in a patient treated with adalimumab. Clin Rheumatol (2006) 1.00
Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int (2001) 0.99
Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. Clin Exp Rheumatol (1988) 0.98
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis. Ann Rheum Dis (2002) 0.97
Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest (1988) 0.97
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol (2010) 0.97
Hearing loss in Sjögren's syndrome patients. A comparative study. Clin Exp Rheumatol (2001) 0.96
Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus (2002) 0.96
Assessment of gastrointestinal involvement. Clin Exp Rheumatol (2003) 0.96
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study. Ann Rheum Dis (1986) 0.95
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol (1989) 0.95
Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. A controlled study. Chest (1986) 0.93
Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis (2007) 0.93
Psychiatric symptoms associated with scleroderma. Psychother Psychosom (2001) 0.93
Xerotrachea and interstitial lung disease in primary Sjogren's syndrome. Respiration (1984) 0.92
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. Int J Antimicrob Agents (2010) 0.92
Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol (1990) 0.92
The gastrointestinal involvement in primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 0.92
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment. Ann Rheum Dis (2005) 0.92
Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. Ann Rheum Dis (1984) 0.91
Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol (2011) 0.91
Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol (1995) 0.91
HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum (1992) 0.91
Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis (2003) 0.91
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study. Ann Rheum Dis (2003) 0.90
Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study. Clin Exp Rheumatol (2012) 0.89
Lymphoma in Sjogren's syndrome. Med Pediatr Oncol (1992) 0.89
Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot study. Ann Rheum Dis (2004) 0.88
The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol (2009) 0.87
Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin Exp Rheumatol (1989) 0.87
Appendiceal diverticulitis in a femoral hernia causing necrotizing fasciitis of the right inguinal region: report of a unique case. Hernia (2011) 0.87
Infliximab treatment in ankylosing spondylitis: an observational study. Ann Rheum Dis (2004) 0.87
Altered sequence of the ETS1 transcription factor may predispose to rheumatoid arthritis susceptibility. Scand J Rheumatol (2012) 0.86
Lactate levels in Brucella arthritis. Rheumatol Int (1984) 0.86
Linear cutaneous lupus erythematosus: a subset of childhood cutaneous lupus erythematosus. Lupus (2009) 0.86
Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol (2009) 0.86
HLA-alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun (1988) 0.85
Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. Int J Dermatol (2008) 0.85
A single pulmonary rheumatoid nodule masquerading as malignancy. Clin Rheumatol (2005) 0.85
Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol (2000) 0.85
Coping with health-stressors and defence styles associated with health-related quality of life in patients with systemic lupus erythematosus. Lupus (2011) 0.85
Imaging of thoracic Wegener's granulomatosis: the computed tomographic appearance. Am J Med (1992) 0.85
Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium. J Antimicrob Chemother (2008) 0.84